secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sigyn Therapeutics, Inc. (SIGY)
CIK:        0001642159
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001493152-24-039594
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 3.02
LLM model:  deepseek-v4-flash:cloud@v2

Sigyn Therapeutics issues 118,700 shares on conversion of $474,793 in debentures at $4.00/share
--------------------------------------------------------------------------------

- Holders of $474,793 in convertible debentures converted at $4.00/share; 118,700 restricted shares issued.
- Outstanding common shares increased from 1,301,978 to 1,420,678 as a result.
- Conversion exempt from registration under Section 4(a)(2); holders are executive-officer-controlled accredited investors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/0001493152-24-039594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1642159/000149315224039594/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-039594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer